TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Deep sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Children sleep habit questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall hearing aid satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decreased urinary loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Collaboration & Satisfaction About Care Decisions (CSACD)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of vsPPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual change in digital biomarkers for bradykinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual change in digital biomarkers for falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual change in digital biomarkers for rising from a chair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With ≥Grade 3 Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Hypoallergenicity of the formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient uptake of the COVID bivalent booster
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Baseline dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Transitional dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain intensity measured by the Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-hospital newborn mortality
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants receiving RBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Visual Analog Scale (VAS) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Event-related Potential (ERP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fundamental frequency f0 (Hz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bailey-4 quantitative scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mayo Score at Initiation of Tofacitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial Mayo Score at Initiation of Tofacitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Ulcerative Colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal anti-spike antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Survival free of organ support at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Electrocardiography (EKG) QTC Interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety blood lab tests
Endpoint domain: Adverse events/effects
Primary endpoint: timing of trunk muscle torque production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amplitude of trunk muscle torque production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual-analogue pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual-analogue anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain Catastrophizing scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of catheter-related bladder discomfort (CRBD)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants achieving SLE Responder Index (4) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target area hair count (TAHC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Wilson's Disease Rating Scale (UWDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence rate of severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma metabolite Traumatic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion with a repeat donation attempt
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Treatment recommendations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Semi-structured interviews
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quantitative acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Qualitative acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preferred skin PMM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of patients with all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: ratio of women with Hb level >11 at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: postpartum Hb level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of Grade ≥3 AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pp65-specific CD137+ CD8+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in sTNFRII
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Height in centimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in AI-ECG signals correlating with HF progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity of disease
Endpoint domain: Mortality/survival
Primary endpoint: Documentation efficiency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VI-RADS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle myoelectric activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot print pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional ankle instability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the PNE4Adults
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comprehensibility of the PNE4Adults
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: liver function changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference between pre and post training scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants that reach or exceed 10 out of 12 on the checklist
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mayo elbow performance score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Breast Cancer Specific Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cancer Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change of MPMspecific VOCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the acetaminophen plasma concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed acetaminophen concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of maximum observed acetaminophen concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain intensity on cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound skill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compassion Competence Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Borg Dyspnea Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDI Recurrence Rate
Endpoint domain: Mortality/survival
Primary endpoint: Use patterns
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative behavioral changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Abdominal Pain Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Refractive Error Profile (PREP) questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean percentage saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The % of correct warnings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of skin irritations
Endpoint domain: Adverse events/effects
Primary endpoint: First cycle DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Fugl-Meyer Upper Extremity Motor Evaluation Scale (FM-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Ashworth scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: Mini Mental state examination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cough Condition Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Phlegm Severity Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Uptake of family history screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Screen result interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Intraocular inflammation (IOI)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of suspected endophthalmitis
Endpoint domain: Adverse events/effects
Primary endpoint: Lympho-protective efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline on Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline on Complete blood count (CBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline on Fasting blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of CSF leak
Endpoint domain: Adverse events/effects
Primary endpoint: Attaining serum phosphorus levels within the normal range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Identification of types of arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in MADRS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean 2-iodoxehadecanal and delta-iodolactone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From 0 to Last Observed Non-zero Concentration [AUC(0-t)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Time Curve From Time '0' Extrapolated to Infinity [AUC(0-inf)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of GIP excretion in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly concentration of GIP excretion in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients excreting GIP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily ratings of target behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Root coverage percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Gingival thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frequency of travelers' diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Etiology of travelers' diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Solicited Local Adverse Events (AEs) for Six Subsequent Days Following First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Serious Adverse Events (SAEs) Until Day 57
Endpoint domain: Adverse events/effects
Primary endpoint: Seroconversion Rate (SCR) of Serum bAb Against SARS-CoV-2 on Day 57
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of sleep problems
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Frequency of psychiatric problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean percent predicted forced expiratory volume in 1 second (ppFEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Belief Scale for Normal Delivery (BSND)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Birth Beliefs (Natural and medical birth belief) Scale (BBS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: level of circulating CD4+ and CD4- T cells expressing CD8αα and CD8αβ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Disability level of participant
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Organ-specific response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self-Reported Depression Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical breakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical slippage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of psilocybin administration
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with clinically significant endoscopic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection sensitivity of urine monoclonal component
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return proportion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cmax for Solifenacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: truncated AUC0→72 for Solifenacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Mirabegron
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0→t for Mirabegron
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0→∞ for Mirabegron
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eHealth Literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-treatment peak eosinophil count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Identifiable pathologic characteristics of bladder tumor specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of Relapse-Free Survival (RFS) in 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Number and severity of adverse events until 100 days after the last study treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Pain intensity (Visual analogue scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity (Pressure algometry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability questionnaire (Victorian institute of sport assessment-patella)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Muscle strength (Hand held dynamometer)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of pelvic and abdominal lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: percentage of pelvic and abdominal lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: coincidence rate of lymph node imaging and diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global rating
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Actual mark
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Total Radioactivity (Cum% Dose) Recovered in Urine Relative to the Administered Radioactive Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Total Radioactivity (Cum% Dose) Recovered in Feces Relative to the Administered Radioactive Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Administered Radioactive Dose (%Dose) Excreted in Urine for [14C]-DZD9008
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Administered Radioactive Dose (%Dose) Excreted in Feces for [14C]-DZD9008
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Algometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Myotonometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Oswestry Low Back Disability Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Composite of all-cause mortality and/or any episode of culture-positive sepsis and/or severe sepsis
Endpoint domain: Mortality/survival
Primary endpoint: Need for intravenous antibiotics for ≥ 48 hours
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean ADHD Rating Scale (ADHD-RS) results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment preferences in acute life-threatening illness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of occurrences of Adverse events/Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Survival of implant at 1 year post operative
Endpoint domain: Mortality/survival
Primary endpoint: Borg scale (CR-10) Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thoracoabdominal expansion measurement through tape measuring tool (cirtometry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity measurement through IPAQ questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: p-mTOR levels in monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maternal complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Infant outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Increase in best-corrected visual acuity (BCVA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: outcomes of Diamond flap versus V-Y flap in treatment of anal stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Modified Medical Research Council scale for breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dyspnoea-12 (Chinese version)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical diagnostic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of imagery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of radiological image artifact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in diagnosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in modified Mayo Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin assessment (RD grade)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient's assessment of the skin condition (DLQI questioner)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cardiac arrhythmia evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Eradication Rate of Helicobacter Pylori Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients with stage 2 pressure injury
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of Autonomic crisis severity assessment scores (ACSAS) to ≤ 5 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 25% reduction in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes